Updated on Aug 7, 2024 Share
Akadeum has secured a $1 million investment led by Michigan eLab, which includes Detroit Innovate, Invest Michigan, University of Michigan MINTS, and Jeffrey Schox, a nationally renowned patient attorney.
“What truly excited us at Michigan eLab was not only the disruptive nature Akadeum’s BACS™ microbubble solution has on the market, but the intense customer focus the founding team had, including embracing lean startup methodologies typically found in software companies,” said Doug Neal, managing director of Michigan eLab and Akadeum board member. “Not many biotech startups have active customers just 18 months after company formation. We are excited about the opportunity for Akadeum to rapidly grow.”
Read more details in the press release.
Related News
Michigan eLab, LLC. is a venture capital firm in Ann Arbor, Michigan. Their first local…
Akadeum closes funding to further commercialize its BACS™ Microbubble platform for next-generation sample preparation applications.…
Akadeum’s groundbreaking microbubble technology—which allows for fast, easy removal of target cells from biological samples—was…
Contact Us
View Resources